Revvity Operating Margin 2010-2025 | RVTY

Current and historical operating margin for Revvity (RVTY) over the last 10 years. The current operating profit margin for Revvity as of March 31, 2025 is 21.70%.
Revvity Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $2.77B $0.38B 13.54%
2024-12-31 $2.76B $0.35B 12.60%
2024-09-30 $2.72B $0.31B 11.20%
2024-06-30 $2.71B $0.28B 10.19%
2024-03-31 $2.73B $0.27B 9.83%
2023-12-31 $2.75B $0.30B 10.91%
2023-09-30 $2.80B $0.36B 12.88%
2023-06-30 $2.84B $0.40B 14.17%
2023-03-31 $3.02B $0.56B 18.39%
2022-12-31 $3.31B $0.74B 22.40%
2022-09-30 $3.00B $0.87B 28.92%
2022-06-30 $3.15B $0.95B 30.25%
2022-03-31 $3.48B $1.05B 30.24%
2021-12-31 $3.83B $1.26B 32.90%
2021-09-30 $3.63B $1.40B 38.41%
2021-06-30 $3.74B $1.45B 38.74%
2021-03-31 $3.32B $1.29B 38.90%
2020-12-31 $2.66B $0.87B 32.59%
2020-09-30 $3.23B $0.61B 18.78%
2020-06-30 $2.98B $0.44B 14.72%
2020-03-31 $2.89B $0.35B 12.26%
2019-12-31 $2.88B $0.36B 12.55%
2019-09-30 $2.84B $0.34B 11.99%
2019-06-30 $2.80B $0.34B 12.17%
2019-03-31 $2.78B $0.34B 12.11%
2018-12-31 $2.78B $0.32B 11.67%
2018-09-30 $2.66B $0.30B 11.34%
2018-06-30 $2.54B $0.30B 11.80%
2018-03-31 $2.39B $0.29B 11.98%
2017-12-31 $2.26B $0.30B 13.11%
2017-09-30 $2.18B $0.29B 13.47%
2017-06-30 $2.14B $0.29B 13.63%
2017-03-31 $2.13B $0.28B 13.33%
2016-12-31 $2.12B $0.30B 13.95%
2016-09-30 $2.00B $0.25B 12.66%
2016-06-30 $2.05B $0.25B 12.35%
2016-03-31 $2.08B $0.26B 12.28%
2015-12-31 $2.11B $0.25B 11.92%
2015-09-30 $2.10B $0.19B 8.88%
2015-06-30 $2.07B $0.17B 8.15%
2015-03-31 $2.07B $0.17B 8.28%
2014-12-31 $2.07B $0.17B 8.02%
2014-09-30 $2.22B $0.28B 12.40%
2014-06-30 $2.20B $0.27B 12.47%
2014-03-31 $2.18B $0.24B 11.18%
2013-12-31 $2.16B $0.23B 10.57%
2013-09-30 $2.13B $0.11B 5.07%
2013-06-30 $2.12B $0.09B 4.39%
2013-03-31 $2.10B $0.10B 4.90%
2012-12-31 $2.11B $0.10B 4.89%
2012-09-30 $2.08B $0.10B 4.95%
2012-06-30 $2.03B $0.10B 4.74%
2012-03-31 $1.98B $0.09B 4.29%
2011-12-31 $1.92B $0.09B 4.69%
2011-09-30 $1.85B $0.17B 9.10%
2011-06-30 $1.81B $0.17B 9.55%
2011-03-31 $1.76B $0.17B 9.52%
2010-12-31 $1.70B $0.16B 9.22%
2010-09-30 $1.54B $0.14B 8.86%
2010-06-30 $1.49B $0.12B 7.84%
2010-03-31 $1.51B $0.12B 8.08%
2009-12-31 $1.55B $0.12B 7.48%
Sector Industry Market Cap Revenue
Medical Medical Services $10.993B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $136.013B 25.51
CVS Health (CVS) United States $78.381B 9.74
Elevance Health (ELV) United States $62.395B 8.39
Cencora (COR) United States $56.765B 19.75
DiDi Global (DIDIY) China $26.874B 28.55
Labcorp Holdings (LH) United States $20.399B 16.55
Natera (NTRA) United States $18.966B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.991B 0.00
CochLear (CHEOY) Australia $13.143B 0.00
Solventum (SOLV) United States $12.678B 13.42
ICON (ICLR) Ireland $11.592B 10.78
Viatris (VTRS) United States $10.422B 3.58
Avantor (AVTR) United States $9.056B 13.16
Medpace Holdings (MEDP) United States $8.964B 23.81
Sonic Healthcare (SKHHY) Australia $8.852B 0.00
HealthEquity (HQY) United States $8.449B 37.01
Caris Life Sciences,�Inc (CAI) United States $7.680B 0.00
Charles River Laboratories (CRL) United States $7.587B 14.87
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.918B 28.96
BrightSpring Health Services (BTSG) United States $3.506B 32.17
Sotera Health (SHC) United States $3.139B 17.84
Surgery Partners (SGRY) United States $2.861B 37.20
Concentras Parent (CON) United States $2.507B 14.49
Organon (OGN) United States $2.459B 2.61
Alignment Healthcare (ALHC) United States $2.455B 0.00
GeneDx Holdings (WGS) United States $2.222B 85.57
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.823B 0.00
Premier (PINC) United States $1.725B 13.09
GoodRx Holdings (GDRX) United States $1.672B 33.43
Ardent Health (ARDT) United States $1.589B 6.77
Teladoc Health (TDOC) United States $1.412B 0.00
QDM (QDMI) Hong Kong, SAR China $1.277B 438.00
Establishment Labs Holdings (ESTA) $1.202B 0.00
Pediatrix Medical (MD) United States $1.080B 8.22
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.878B 0.00
AMN Healthcare Services Inc (AMN) United States $0.759B 7.10
CareDx (CDNA) United States $0.663B 10.36
Nutex Health (NUTX) United States $0.632B 9.57
So-Young (SY) China $0.595B 0.00
SBC Medicals (SBC) United States $0.585B 0.00
Embecta (EMBC) United States $0.572B 3.85
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.479B 0.00
Auna S.A (AUNA) Luxembourg $0.470B 10.58
Sonida Senior Living (SNDA) United States $0.466B 0.00
Omada Health (OMDA) $0.453B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.402B 0.00
Enhabit (EHAB) United States $0.342B 28.12
Oncology Institute (TOI) United States $0.312B 0.00
Performant Healthcare (PHLT) United States $0.297B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Pheton Holdings (PTHL) China $0.146B 0.00
DocGo (DCGO) United States $0.146B 23.83
Sera Prognostics (SERA) United States $0.110B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
KindlyMD (NAKA) United States $0.066B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Biodesix (BDSX) United States $0.047B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
ModivCare (MODV) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.043B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00